Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Rivat

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Cancer Research|September 5, 2002
The c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapySamir Attoub, Christine Rivat, Sylvie Rodrigues, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 6, 2003
Synergistic cooperation between the AP-1 and LEF-1 transcription factors in activation of the matrilysin promoter by the src oncogene: implications in cellular invasionChristine Rivat, Nathalie Le Floch, Michèle Sabbah, et al.
Nature Cancer|August 4, 2021
Clonal expansion of T memory stem cells determines early anti-leukemic responses and long-term CAR T cell persistence in patientsLuca Biasco, Natalia Izotova, Christine Rivat, et al.
Nature Communications|March 13, 2021
Long-term lymphoid progenitors independently sustain naïve T and NK cell production in humansNatalia Izotova, Christine Rivat, Cristina Baricordi, et al.
Cancer Research|January 25, 2005
Implication of STAT3 signaling in human colonic cancer cells during intestinal trefoil factor 3 (TFF3) -- and vascular endothelial growth factor-mediated cellular invasion and tumor growthChristine Rivat, Rivat Christine, Sylvie Rodrigues, et al.
Human Gene Therapy|March 20, 2021
Preclinical Optimization and Safety Studies of a New Lentiviral Gene Therapy for p47<sup>phox</sup>-Deficient Chronic Granulomatous DiseaseAndrea Schejtman, Winston Vetharoy, Uimook Choi, et al.
Blood|July 19, 2017
Gene therapy for Wiskott-Aldrich syndrome in a severely affected adultEmma C Morris, Thomas Fox, Ronjon Chakraverty, et al.
Science Translational Medicine|January 27, 2017
Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cellsWaseem Qasim, Hong Zhan, Sujith Samarasinghe, et al.
Research and Practice in Thrombosis and Haemostasis|December 17, 2024
Efficacy, safety, and quality of life 4 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A in the phase 3 GENEr8-1 trialAndrew D Leavitt, Johnny Mahlangu, Priyanka Raheja, et al.
JAMA|April 22, 2015
Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndromeSalima Hacein-Bey Abina, H Bobby Gaspar, Johanna Blondeau, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cancer Research|September 5, 2002
The c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapySamir Attoub, Christine Rivat, Sylvie Rodrigues, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 6, 2003
Synergistic cooperation between the AP-1 and LEF-1 transcription factors in activation of the matrilysin promoter by the src oncogene: implications in cellular invasionChristine Rivat, Nathalie Le Floch, Michèle Sabbah, et al.
Nature Cancer|August 4, 2021
Clonal expansion of T memory stem cells determines early anti-leukemic responses and long-term CAR T cell persistence in patientsLuca Biasco, Natalia Izotova, Christine Rivat, et al.
Nature Communications|March 13, 2021
Long-term lymphoid progenitors independently sustain naïve T and NK cell production in humansNatalia Izotova, Christine Rivat, Cristina Baricordi, et al.
Cancer Research|January 25, 2005
Implication of STAT3 signaling in human colonic cancer cells during intestinal trefoil factor 3 (TFF3) -- and vascular endothelial growth factor-mediated cellular invasion and tumor growthChristine Rivat, Rivat Christine, Sylvie Rodrigues, et al.
Human Gene Therapy|March 20, 2021
Preclinical Optimization and Safety Studies of a New Lentiviral Gene Therapy for p47<sup>phox</sup>-Deficient Chronic Granulomatous DiseaseAndrea Schejtman, Winston Vetharoy, Uimook Choi, et al.
Blood|July 19, 2017
Gene therapy for Wiskott-Aldrich syndrome in a severely affected adultEmma C Morris, Thomas Fox, Ronjon Chakraverty, et al.
Science Translational Medicine|January 27, 2017
Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cellsWaseem Qasim, Hong Zhan, Sujith Samarasinghe, et al.
Research and Practice in Thrombosis and Haemostasis|December 17, 2024
Efficacy, safety, and quality of life 4 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A in the phase 3 GENEr8-1 trialAndrew D Leavitt, Johnny Mahlangu, Priyanka Raheja, et al.
JAMA|April 22, 2015
Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndromeSalima Hacein-Bey Abina, H Bobby Gaspar, Johanna Blondeau, et al.
Pageof 3